PurCann Pharma is a finalist at ADRIQ’s Innovation Awards Gala
Purcann Pharma has been selected as a finalist in the “Innovation | Life Sciences” category by ADRIQ (Quebec Association for the Development of Research and Innovation)
Canaquest signs Mentanine® and Mentabinol® production and distribution agreement with Purcann Pharma
This agreement signed with PurCann Pharma facilitates CanaQuest’s planned production, distribution and global export of Mentanine® and Mentabinol® formulations
Raif Kadri is appointed Vice President Global Sales of PurCann Pharma
Active in sales to the global pharmaceutical industry for the past 25 years, Mr. Kadri, a biochemist by education, has been in charge of sales at SiliCycle Inc. for the past 15 years
SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC)
SiliCycle management is pleased to have signed a Letter of Intent with the Quebec Cannabis Society (SQDC) for the supply of its Tyche™ brand products in 2021.
Pierre Plante joins PurCann Pharma
PurCann Pharma’s President Hugo St-Laurent is proud to announce the appointment of Pierre Plante as Vice-President – CMO & API for the company
See you at the 2nd Canadian Cannabis Conference Webinar, October 7th, 2020
Hosted by PurCann Pharma and SiliCycle, this event will gather experts for an overview of the cannabis industry: research, market, production…
